Compare Cenovus Energy Inc (CVE) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cenovus Energy Inc vs Health Care Select Sector SPDR Fund — how do they compare? Cenovus Energy Inc trades at $31.39 (market cap $57.90B), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Cenovus Energy Inc is the larger of the two by market cap, and Cenovus Energy Inc pays a 1.97% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cenovus Energy Inc for 46 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| CVE | XLV | |
|---|---|---|
Market Cap | $57.90B | $43.48B |
Volume | 7,863,588 | 11,121,431 |
Sector | Energy | — |
52-Week High | $33.92 | $175.68 |
52-Week Low | $15.85 | $141.95 |
Typical Hold Time | 46 Days | 100 Days |
Enterprise Value | $63.84B | — |
Dividend Yield | 1.97% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cenovus Energy (CVE) trades at $31.49, up 2.81% with bullish technical momentum. The stock shows strong fundamentals with a P/E of 12.43 and EV/EBITDA of 6.17, trading near 52-week highs. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results pending. Operating cash flow remains robust at $8.23B despite negative net cash flow in 2025. Analyst consensus is mixed with 40.7% buy ratings amid positive media coverage highlighting growth potential.
CVE presents a compelling value opportunity with attractive valuation metrics and improving profitability. The main investment thesis centers on earnings growth recovery and operational efficiency gains. Key risks include oil price volatility and execution challenges in capital expenditure management. Institutional ownership trends and recent analyst upgrades support a cautiously optimistic outlook for medium-term appreciation.
XLV trades at $168.16, down 0.39% with a bearish technical signal from moving averages. The healthcare ETF maintains strong cost advantages with a 0.08% expense ratio compared to peers. Recent news highlights XLV's defensive positioning during market volatility and its historical outperformance during Fed rate hikes. Technical indicators show RSI levels in neutral territory while ADX signals selling pressure.
XLV offers diversified healthcare exposure with competitive expense ratios, positioning it well for defensive investing. Key risks include political uncertainty around healthcare policy and concentrated exposure to domestic S&P 500 stocks. The ETF's low-cost structure and sector diversification provide stability amid market volatility, though technical indicators suggest near-term caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cenovus Energy Inc
Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 472 thousand barrels of oil equivalent per day in 2020, and the company estimates that it holds 6.7 billion boe of proven and probable reserves.
Read more on CVE →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
